Aarti Pharmalabs Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 662 as of 15 Jun 09:06 . The p/e ratio of Aarti Pharmalabs Ltd changed from 12.9 to 24.9 over 3 quarters. This represents a CAGR of 140.33% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The market cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore to ₹ 6784 crore over 3 quarters. This represents a CAGR of 280.75% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The revenue of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 596.21 crore as compare to the Dec '25 revenue of ₹ 436.83 crore. This represent the growth of 36.49% The revenue of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 126.7 crore as compare to the Dec '25 ebitda of ₹ 104.07 crore. This represent the growth of 21.74% The ebitda of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aarti Pharmalabs Ltd changed from ₹ 55.45 crore to ₹ 61.12 crore over 8 quarters. This represents a CAGR of 4.99% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Aarti Pharmalabs Ltd changed from 10.55 % to 17.61 % over 3 quarters. This represents a CAGR of 98.00% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019.
The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022.
Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Aarti Pharmalabs Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Aarti Pharmalabs Ltd or Sanofi India Ltd?

Market cap of Aarti Pharmalabs Ltd is 5,813 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Aarti Pharmalabs Ltd and Sanofi India Ltd?

The stock performance of Aarti Pharmalabs Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Pharmalabs Ltd and Sanofi India Ltd?

As of June 15, 2026, the Aarti Pharmalabs Ltd stock price is INR ₹641.25. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Aarti Pharmalabs Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Aarti Pharmalabs Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.